Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Surgery

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1067/MSY.2002.125389PMID 12219026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological differences among MCF-7 human breast cancer cell lines from different laboratories

  2005cited by this paper
• ERK5 and ERK2 Cooperate to Regulate NF-κB and Cell Transformation*

  2001cited by this paper
• Neurotrophins use the Erk5 pathway to mediate a retrograde survival response

  2001cited by this paper
• Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.

  2001cited by this paper
• ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation.

  2001cited by this paper
• DNA microarrays: revolutionary insight into the living genome.

  2001cited by this paper
• Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

  2001cited by this paper
• Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells.

  2001cited by this paper
• NF-kappa B-mediated chemoresistance in breast cancer cells.

  2001cited by this paper
• NF-κB–mediated chemoresistance in breast cancer cells

  2001cited by this paper
• Signal transduction by target-derived neurotrophins

  2001cited by this paper
• Granulocyte Colony-stimulating Factor Induces Erk5 Activation, Which Is Differentially Regulated by Protein-tyrosine Kinases and Protein Kinase C

  2001cited by this paper
• MEK5, a New Target of the Atypical Protein Kinase C Isoforms in Mitogenic Signaling

  2001cited by this paper
• Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals.

  2001cited by this paper
• Neurotrophins use the Erk5 pathway to mediate a retrograde survival response

  2001cited by this paper
• A Novel Mitogen-Activated Protein Kinase Is Responsive to Raf and Mediates Growth Factor Specificity

  2001cited by this paper
• PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis.

  2000cited by this paper
• Cross-talk between Phosphatidylinositol 3-Kinase and Sphingomyelinase Pathways as a Mechanism for Cell Survival/Death Decisions*

  2000cited by this paper
• Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants.

  2000cited by this paper
• Epidermal Growth Factor Protects Epithelial Cells against Fas-induced Apoptosis

  1999cited by this paper
• MEKK3 Directly Regulates MEK5 Activity as Part of the Big Mitogen-activated Protein Kinase 1 (BMK1) Signaling Pathway*

  1999cited by this paper
• Contribution of the ERK5/MEK5 Pathway to Ras/Raf Signaling and Growth Control*

  1999cited by this paper
• Activation of the Protein Kinase ERK5/BMK1 by Receptor Tyrosine Kinases

  1999cited by this paper
• Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants.

  1998cited by this paper
• Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor

  1998cited by this paper
• BMK1/ERK5 regulates serum‐induced early gene expression through transcription factor MEF2C

  1997cited by this paper
• Hyperexpression of mitogen-activated protein kinase in human breast cancer.

  1997cited by this paper
• Primary structure of BMK1: a new mammalian map kinase.

  1995cited by this paper
• Components of a New Human Protein Kinase Signal Transduction Pathway (*)

  1995cited by this paper
• Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics

  1972cited by this paper
• The Use of Ranks to Avoid the Assumption of Normality Implicit in the Analysis of Variance

  1937cited by this paper

• Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer

  2021cites this paper
• Targeted Avenues for Cancer Treatment: The MEK5-ERK5 Signaling Pathway.

  2020cites this paper
• Reversal of ABCB1-related multidrug resistance by ERK5-IN-1

  2020cites this paper
• Impact of ERK5 on the Hallmarks of Cancer

  2019cites this paper
• Dual Inhibition of the PI3K/Akt and MEK5/ERK5 Pathways for the Treatment of Breast Cancer

  2019cites this paper
• Network Pharmacology and Reverse Molecular Docking-Based Prediction of the Molecular Targets and Pathways for Avicularin Against Cancer.

  2019cites this paper
• ERK5‑regulated RERG expression promotes cancer progression in prostatic carcinoma.

  2018cites this paper
• MEK 5-ERK 5 Signaling in Cancer : Implications for Targeted Therapy

  2018influential citation
• The Pharmacological Inhibition of ERK5 Enhances Apoptosis in Acute Myeloid Leukemia Cells

  2018cites this paper
• Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma

  2017cites this paper
• Oncogenic signaling of MEK5-ERK5.

  2017cites this paper
• Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response*

  2017cites this paper
• The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.

  2016cites this paper
• MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism

  2016cites this paper
• MEK5 overexpression is associated with the occurrence and development of colorectal cancer

  2016cites this paper
• The MEK 5 / ERK 5 signalling pathway in cancer : a promising novel therapeutic target

  2016cites this paper
• Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site

  2016cites this paper
• Bacterial Effector Nanoparticles as Breast Cancer Therapeutics.

  2016cites this paper
• ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation

  2016cites this paper
• MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma

  2016cites this paper
• Phosphorylation of BMK1 induces prostatic carcinoma cell proliferation by promoting entry into the S phase of the cell cycle

  2015cites this paper
• Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L

  2015cites this paper
• Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation

  2015cites this paper
• Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma

  2015cites this paper
• Inhibition of BMK 1 pathway suppresses cancer stem cells through BNIP 3 and BNIP 3 L

  2015cites this paper
• Elevated expression of long intergenic non‐coding RNA HOTAIR in a basal‐like variant of MCF‐7 breast cancer cells

  2015cites this paper
• Inhibition of ERK 5 enhances cytarabine-induced apoptosis in acute myeloid leukemia cells

  2015cites this paper
• Inhibition of ERK5 enhances cytarabine-induced apoptosis in acute myeloid leukemia cells.

  2015cites this paper
• Extracellular signal–regulated kinase 5 promotes acute cellular and systemic inflammation

  2015cites this paper
• The regulatory role of mixed lineage kinase 4 beta in MAPK signaling and ovarian cancer cell invasion

  2013cites this paper
• Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition

  2013cites this paper
• SIGNAL TRANSDUCTION PATHWAY ANALYSIS OF LUNG CANCER THAT MAY PROVIDE POTENTIAL DRUG TARGET IDENTIFICATION

  2013cites this paper
• MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis

  2013cites this paper
• The Role of ERK5 in Cell Proliferation

  2013cites this paper
• Role of p90(RSK) in regulating the Crabtree effect: implications for cancer.

  2013cites this paper
• Age-related effects on the mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in breast cancer and the characterization of novel MEK5 inhibitors

  2013cites this paper
• ERK5 and its role in tumour development.

  2012cites this paper
• Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer

  2012cites this paper
• Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells

  2012cites this paper
• MEK5/ERK5 pathway: the first fifteen years.

  2012cites this paper
• BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction

  2012cites this paper
• Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance.

  2012cites this paper
• Expression of the phosphorylated MEK5 protein is associated with TNM staging of colorectal cancer

  2012cites this paper
• ERK5: structure, regulation and function.

  2012cites this paper
• Targeting the BMK1 MAP Kinase Pathway in Cancer Therapy

  2011cites this paper
• Molecular Pathways Targeting the BMK 1 MAP Kinase Pathway in Cancer Therapy

  2011cites this paper
• Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1

  2011cites this paper
• Sphingosine kinase: A promising cancer therapeutic target

  2011cites this paper
• Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer.

  2011cites this paper
• Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640.

  2010cites this paper
• Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.

  2010influential citation
• Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin

  2010cites this paper
• A novel role of ERK5 in integrin‐mediated cell adhesion and motility in cancer cells via Fak signaling

  2009cites this paper
• ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry

  2009cites this paper
• Tumor suppressive effects of the beta -2 adrenergic receptor and the small GTPase RhoB

  2008cites this paper
• ERK5/MAPK is activated by TGFbeta in hepatocytes and required for the GSK-3beta-mediated Snail protein stabilization.

  2008cites this paper
• Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype

  2008cites this paper
• Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.

  2007cites this paper
• A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway

  2007cites this paper
• Protein kinase Cι: Human oncogene, prognostic marker and therapeutic target

  2007cites this paper
• Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

  2007cites this paper
• TITLE: Investigation of the Role of Breast Tumor Kinase (Brk) in ERK5 and p38-Mediated Breast Cancer Cell

  2007cites this paper
• Influence of Sutherlandia frutescens extracts on cell numbers, morphology and gene expression in MCF-7 cells.

  2007cites this paper
• ERK5 Activates NF-κB in Leukemic T Cells and Is Essential for Their Growth In Vivo1

  2006cites this paper
• MEK1/2 inhibition promotes Taxotere® lethality in mammary tumors in vivo

  2006cites this paper
• Response and Resistance to Ionizing Radiation

  2006cites this paper
• The use of microarray data integration to improve cancer prognosis

  2006cites this paper
• Big mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis.

  2005cites this paper
• Evaluation of potential Stat3-regulated genes in human breast cancer.

  2005cites this paper
• The Unique C-terminal Tail of the Mitogen-activated Protein Kinase ERK5 Regulates Its Activation and Nuclear Shuttling*

  2005cites this paper
• DNA array-based gene profiling: from surgical specimen to the molecular portrait of cancer.

  2005cites this paper
• Automated oncogene detection in complex protein networks with applications to the MAPK signal transduction pathway.

  2005cites this paper
• A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.

  2005cites this paper
• Abl‐kinase‐sensitive levels of ERK5 and its intrinsic basal activity contribute to leukaemia cell survival

  2005cites this paper
• Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells

  2005cites this paper
• Chemogenomics: an emerging strategy for rapid target and drug discovery

  2004cites this paper
• Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice

  2004cites this paper
• Stat3 upregulates MEK5 expression in human breast cancer cells

  2004influential citation
• Differential role of MEK5alpha and MEK5beta in BMK1/ERK5 activation.

  2004cites this paper
• Genomics-based hypothesis generation: a novel approach to unravelling drug resistance in brain tumours?

  2004cites this paper
• Global Gene Expression Analysis of Human Bronchial Epithelial Cells Treated with Tobacco Condensates

  2004cites this paper
• Mitogen-activated protein kinases in apoptosis regulation

  2004cites this paper
• MAPK pathways in radiation responses

  2003cites this paper
• Apoptosis, Chemoresistance, and Breast Cancer: Insights From the MCF-7 Cell Model System

  2003cites this paper
• Differential Role of MEK5α and MEK5β in BMK1/ERK5 Activation*

  2003cites this paper
• Recent publications by ochsner authors.

  2003cites this paper
• Sequence Dependent Exposure of Mammary Carcinoma Cells to Taxotere® and the MEK1/2 Inhibitor U0126 Causes Enhanced Cell Killing In Vitro

  2003cites this paper
• Recent Publications by Ochsner Authors

  2001cites this paper